Breaking News Instant updates and real-time market news.

ANTH

Anthera

$0.44

0.001 (0.23%)

16:04
03/20/17
03/20
16:04
03/20/17
16:04

Anson Funds Management reports 6.2% passive stake in Anthera

ANTH Anthera
$0.44

0.001 (0.23%)

12/29/16
SBSH
12/29/16
DOWNGRADE
Target $0.9
SBSH
Neutral
Anthera downgraded to Neutral from Buy at Citi
Citi analyst Yigal Nochomovitz downgraded Anthera Pharmaceuticals to Neutral and cut his price target for the shares to 90c from $6. Yesterday's failed Phase III study brings up new concerns on Sollpura's value proposition and an immediate financing overhang, Nochomovitz tells investors in a research note. The shares closed yesterday down 63% to 74c.
12/29/16
JEFF
12/29/16
DOWNGRADE
Target $1
JEFF
Hold
Anthera downgraded to Hold from Buy at Jefferies
Jefferies analyst Matthew Andrews downgraded Anthera Pharmaceuticals to Hold citing a lower probability of success for Sollpura following yesterday's failed Phase III study. The analyst cut his price target for the shares to $1 from $5. Citi this morning also downgraded Anthera.
12/29/16
12/29/16
NO CHANGE

On The Fly: Top five analyst actions
Catch up on today's top five analyst upgrades, downgrades, and initiations with this list compiled by The Fly: 1. Basic Energy (BAS) upgraded to Accumulate from Hold at Johnson Rice. 2. GameStop (GME) upgraded to Buy from Hold at Standpoint Research. 3. Anthera (ANTH) downgraded to Neutral from Buy at Citi and to Hold from Buy at Jefferies. 4. Senior Housing (SNH) initiated with an Overweight at Cantor. 5. Intrexon (XON) initiated with an Outperform at Northland with analyst Robert Breza saying valuation is compelling and its DNA analysis and engineering platform addresses a large market opportunity. The analyst views Deere's FY17 guidance as achievable. He kept an Outperform rating on the shares with a $117 price target. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/14/17
PIPR
03/14/17
NO CHANGE
Target $1
PIPR
Overweight
Piper cuts Anthera target to $1 following capital raise
Piper Jaffray analyst Edward Tenthoff lowered his price target for Anthera Pharmaceuticals to $1.00 from $1.35 after the company issued 30M units at 50c. The deal is dilitive but enables the start of the Phase III RESULT trial, Tenthoff tells investors in a research note. The analyst maintains an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

F

Ford

$11.01

0.14 (1.29%)

11:32
05/22/17
05/22
11:32
05/22/17
11:32
Recommendations
Ford analyst commentary  »

Ford change too late this…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:30
05/22/17
05/22
11:30
05/22/17
11:30
General news
U.S. VIX equity volatility sank 4% to 11.56 »

U.S. VIX equity…

MRK

Merck

$64.16

0.375 (0.59%)

11:25
05/22/17
05/22
11:25
05/22/17
11:25
Hot Stocks
Merck says Phase 2 study results warrant continued evaluation of MK-7264 »

Merck announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 27

    May

  • 31

    May

  • 02

    Jun

  • 05

    Jun

  • 09

    Jun

  • 14

    Jun

LC

LendingClub

$5.92

0.26 (4.59%)

, ONDK

On Deck Capital

$3.71

0.32 (9.44%)

11:23
05/22/17
05/22
11:23
05/22/17
11:23
Periodicals
Online lendeers attract bond buyers, WSJ says »

According to…

LC

LendingClub

$5.92

0.26 (4.59%)

ONDK

On Deck Capital

$3.71

0.32 (9.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

MGM

MGM Resorts

$31.66

0.41 (1.31%)

11:20
05/22/17
05/22
11:20
05/22/17
11:20
Options
Notable option blocks in MGM »

Notable option blocks in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:17
05/22/17
05/22
11:17
05/22/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
05/22/17
05/22
11:16
05/22/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTBC

Medical Transcription Billing

$1.90

0.02 (1.06%)

11:15
05/22/17
05/22
11:15
05/22/17
11:15
Hot Stocks
MTBC jumps after announcing releases of app for smartphones »

Earlier today, MTBC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
05/22/17
05/22
11:15
05/22/17
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

11:15
05/22/17
05/22
11:15
05/22/17
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

XOM

Exxon Mobil

$82.08

0.147 (0.18%)

11:13
05/22/17
05/22
11:13
05/22/17
11:13
Hot Stocks
Exxon Mobil completes polyethylene lines at Texas plant »

ExxonMobil Chemical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

XOP

SPDR Oil Exploration and Production Fund

$35.37

-0.15 (-0.42%)

11:10
05/22/17
05/22
11:10
05/22/17
11:10
Options
Upside call buying in SPDR Oil Exploration and Production ETF »

Upside call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:10
05/22/17
05/22
11:10
05/22/17
11:10
General news
Treasury announced a $55 B 4-week bill auction for Tuesday »

Treasury announced a $55…

ORBK

Orbotech

$36.72

0.35 (0.96%)

11:09
05/22/17
05/22
11:09
05/22/17
11:09
Hot Stocks
Orbotech sinks after disclosing criminal probe by Israel Tax Authority »

Orbotech earlier today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

AVY

Avery Dennison

$83.18

0.42 (0.51%)

11:09
05/22/17
05/22
11:09
05/22/17
11:09
Hot Stocks
Avery Dennison acquires Finesse Medical »

Avery Dennison…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORBK

Orbotech

$36.72

0.35 (0.96%)

11:08
05/22/17
05/22
11:08
05/22/17
11:08
Downgrade
Orbotech rating change  »

Orbotech downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

RPT

Ramco-Gershenson

$12.75

-0.16 (-1.24%)

11:08
05/22/17
05/22
11:08
05/22/17
11:08
Conference/Events
Ramco-Gershenson management to meet with Jefferies »

Meeting to be held in Las…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

AVT

Avnet

$36.98

-0.1099 (-0.30%)

11:06
05/22/17
05/22
11:06
05/22/17
11:06
Hot Stocks
Avnet named exclusive global distributor for Silego Technology »

Avnet and Silego…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:05
05/22/17
05/22
11:05
05/22/17
11:05
General news
4-Week Bill Announcement Offering Amount data reported »

4-Week Bill Announcement…

RARX

RA Pharmaceuticals

$24.62

-0.32 (-1.28%)

11:04
05/22/17
05/22
11:04
05/22/17
11:04
Conference/Events
RA Pharmaceuticals management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 24

    May

  • 25

    May

  • 22

    Jun

BBRY

BlackBerry

$10.38

0.27 (2.67%)

11:00
05/22/17
05/22
11:00
05/22/17
11:00
Options
Blackberry calls active as the rally continues »

Blackberry calls active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

QUOT

Quotient Technology

$11.30

0.05 (0.44%)

10:58
05/22/17
05/22
10:58
05/22/17
10:58
Conference/Events
Quotient Technology management to meet with Maxim »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

QUOT

Quotient Technology

$11.30

0.05 (0.44%)

10:57
05/22/17
05/22
10:57
05/22/17
10:57
Conference/Events
Quotient Technology management to meet with Loop »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

RHHBY

Roche

$34.30

0.495 (1.46%)

10:57
05/22/17
05/22
10:57
05/22/17
10:57
Hot Stocks
FDA approves Roche's Actemra for giant cell arteritis »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 06

    Jun

  • 26

    Jun

PQ

PetroQuest

$2.42

0.1285 (5.61%)

10:56
05/22/17
05/22
10:56
05/22/17
10:56
Conference/Events
PetroQuest management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 25

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.